About
Apexray Biotech focuses on international pharmaceutical business development and licensing across Europe, the US, Japan, Asia-Pacific (APAC), and ROW. Core areas include API, Finished Dosage Forms, CDMO/CMO partnerships, and licensing-out and opportunities for generic, 505(b)(2) and clinical-stage new drug.
The emphasis is on practical cross-border BD execution – assessing technical, regulatory and market factors, identifying suitable partners, and driving structured deal processes for API supply, contract manufacturing and licensing agreements.
Global Reach
Cross-border BD requires more than connecting markets on a map. It means understanding how market priorities, regulatory pathways and partnership structures differ between Europe, North America, Japan, Asia and other regions, and using those insights to shape realistic, commercially focused growth options in competitive pharmaceutical markets.
